Bio-Techne (TECH) Operating Leases (2019 - 2026)

Bio-Techne's Operating Leases history runs 8 years deep, the most recent figure standing at $76.1 million for Q1 2026.

• In Q1 2026, Operating Leases fell 4.16% year-over-year to $76.1 million; the TTM figure through Mar 2026 stood at $76.1 million (down 4.16% YoY), while the FY2025 annual figure was $84.0 million, down 4.17% from the prior year.
• Operating Leases was $76.1 million for Q1 2026 at Bio-Techne, down from $77.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $97.3 million in Q3 2023 to a low of $56.3 million in Q1 2022.
• Historically, Operating Leases has averaged $81.3 million across 5 years, with a median of $81.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Leases decreased 15.67% in 2022, then soared 65.52% in 2023.
• A 5-year view of Operating Leases shows it stood at $78.2 million in 2022, then rose by 22.82% to $96.0 million in 2023, then retreated by 15.01% to $81.6 million in 2024, then dropped by 5.43% to $77.2 million in 2025, then slipped by 1.35% to $76.1 million in 2026.
• The last three Operating Leases figures came in at $76.1 million (Q1 2026), $77.2 million (Q4 2025), and $80.7 million (Q3 2025), per Business Quant data.